Evidence map›Paper›PMID 37803837›Full record

Trial reportZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study].

Z Y Shen, X C Chen, H R Shan, T Jia, W Y Gu, F Wang, Q L Teng, L Wang, C L Wang, Y Y Shi and 10 more

Open access · greenAbstract readRandomized Controlled TrialMulticenter StudyEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 1 country.

Z Y ShenDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China.
X C ChenDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
H R ShanDepartment of Hematology, Shuyang Hospital of Traditional Chinese Medicine, Suqian 223600, China.
T JiaDepartment of Hematology, the First People's Hospital of Lianyungang, Lianyungang 222002, China.
W Y GuDepartment of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, China.
F WangDepartment of Hematology, the First People's Hospital of Changzhou, Changzhou 213003, China.
Q L TengDepartment of Hematology, Taian Central Hospital, Taian 271000, China.
L WangDepartment of Hematology, Taian Central Hospital, Taian 271000, China.
C L WangDepartment of Hematology, Huai'an First People's Hospital, Huaian 223000, China.
Y Y ShiDepartment of Hematology, Huai'an First People's Hospital, Huaian 223000, China.
H ZhangDepartment of Hematology, the Affiliated Hospital of Jining Medical University, Jining 272000, China.
Y Q MiaoDepartment of Hematology, Yancheng First People's Hospital, Yancheng 224001, China.
T G ZhuDepartment of Hematology, the General Hospital of Wanbei Coal-Electric Group, Suzhou 234000, China.
C Y JiDepartment of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China.
J J YeDepartment of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China.
M Z ZhangDepartment of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
X D ZhangDepartment of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
L WangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
K L XuDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
W SangDepartment of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
Xuzhou Medical College · CNFirst Affiliated Hospital of Zhengzhou University · CNHuaian First People’s Hospital · CNQilu Hospital of Shandong University · CNTaian City Central Hospital · CNThe First People's Hospital of Changzhou · CNAffiliated Hospital of Jining Medical University · CNAnyang Hospital of Traditional Chinese Medicine · CNBeijing Tongren Hospital · CNChina Coal Technology and Engineering Group Corp (China) · CNNantong University · CNThe First People’s Hospital of Lianyungang · CN

Funding

Key Social Development Project of Jiangsu Science and Technology Department BE2019638Key Young Medical Talents of Jiangsu Province QNRC2016791Natural Science Foundation of Jiangsu Province BK20171181
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsparaginaseLymphoma, Extranodal NK-T-CellAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDNAEtoposideHumansMaleMethotrexateMiddle AgedPolyethylene GlycolsPrognosisRetrospective StudiesTreatment OutcomeAsparaginaseCyclophosphamideDNAEtoposideMethotrexatepegaspargasePolyethylene GlycolsAsparaginaseLymphoma, extranodal NK-T-cellPegaspargasePrognosis

Identifiers

PMID37803837
PMCPMC10520233
OpenAlexW4387420847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.